Open-sourcing my cancer has done something I didn't expect. It's brought some brilliant people into my corner: oncologists, genomics researchers, vaccine developers. Each of them has given me something I wouldn't have found on my own.
The problem is that they've all arrived separately, and none of them can talk to each other. Every conversation runs through me. I'm the bottleneck, and I'm not qualified to be one.
So I'm getting them in one room.
What's happening
Cancer Patient Lab run hackathons on individual patients. Not a conference, not a webinar — an hour spent on one person's case, with whoever turns up pulling it apart. They started doing it in 2020 for someone who had run out of options, and he came out of it with a next treatment and the knowledge that he'd turned over every stone.
Mine is on Wednesday 25 November, 5–6pm UK, online. It's timed to land just after my latest results, which are now in and published: bloods on 28 October (CEA 46.5, ALP down to 149), and the restaging CT the same day.
Two ways to get involved
1. The hackathon. A one-hour online session on 25 November. Just RSVP at the link and come along.
2. The care circle. A private, longer-term space where people can see my records and my questions, and talk to each other rather than through me. If that sounds more useful to you than an hour on a Wednesday, message me for an invite.
Do one, or both.
Who I'd especially like to hear from
- Colorectal oncologists, especially anyone who knows the UK and European trial landscape
- Interventional radiologists and ablation specialists
- Genomics people and bioinformaticians
- Personalised vaccine and immunotherapy researchers
- Supportive care specialists who can help make chemo less shit to live with
What you'd be working from
Everything is already published. My One View is the whole case on one sheet: diagnosis, genetics, every treatment and how it went, latest bloods, what I take. There's a clinician brief if you want the half-page version, and the full record underneath it with every blood test, scan report and the raw sequencing files.
Worth knowing before you come: my sequencing so far is a 517-gene tumour-only panel. No whole genome, no RNA-seq. That gap is one of the things I want to talk about.
What the scan changed
Update, 3 November. The CT showed a partial response — the lung metastases and chest nodes have shrunk, the liver lesion is stable. At the results call on 2 November we agreed the plan: drop the irinotecan, and continue 5-FU and cetuximab as maintenance from Cycle 7, around 12 November. The aim is to hold things where they are and keep the cough away, rather than chase more shrinkage. After this line: Lonsurf and bevacizumab, then trials, then fruquintinib or regorafenib.
Which is good news, and it has not closed the questions down so much as moved them. Does 5-FU and bevacizumab before Lonsurf keep the antibody–drug conjugate trials open to me? The liver lesion is parked until the next scan, but is that the right call? Whole genome sequencing on tissue is not funded and needs fresh frozen tissue, so an NGS blood test is proposed instead — what would you actually do with it? And when a rechallenge gives a slightly smaller response each time, how long does maintenance realistically hold?
Update, 13 November. Latest, and useful if you're coming: I'm off irinotecan from cycle 7 (12 Nov), and my CEA has more than doubled to 104 on 11 November, two weeks after the scan above showed a partial response. Repeat bloods are on 25 November — the day of the hackathon. Written up here.
Update, 4 November. The written radiology reports are now in and published, for the 28 October scan and the July one before it — identifiers redacted, findings untouched, on the full record. Worth knowing before you come: the October report describes the response but gives no lesion measurements. The July report does. So if you want to measure anything yourself, you will want the images.
I have those too. I hold the complete original DICOM studies, downloaded from the hospital portal and kept untouched. They are not published — they are full of identifying metadata and most tools cannot read them anyway — but I will share them individually: clinicians through the hospital's image-sharing system, reviewers as an anonymised copy on a private, time-limited link. Ask me and say what you want to look at.
So the pack is complete. Reports, bloods, genomics, the raw sequencing files, the daily log, and the images on request. The clinic letter is the last thing outstanding. Those questions are the crux of the hackathon conversation. That's really what I want the hour for: not a verdict on the scan, but the argument about what follows it.
The rules, such as they are
It's informal and voluntary, with no obligation on anyone. Nothing said in the room is a treatment decision — everything goes back to my oncologist as questions, and I'm hoping she'll join. I'll share whatever comes out of it, publicly, so it might be useful to someone else with a similar profile.
And the usual ask: no juices, no books, no anecdotes about someone's uncle. Specialists and people who know this disease, please.
If you've been following this and wondering whether any of it actually goes anywhere — this is where it goes.
— Russ